Compare SUPN & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | CMPR |
|---|---|---|
| Founded | 2005 | 1994 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.2B |
| IPO Year | 2010 | 2005 |
| Metric | SUPN | CMPR |
|---|---|---|
| Price | $41.74 | $84.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $61.60 | ★ $86.50 |
| AVG Volume (30 Days) | ★ 511.5K | 167.8K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 553.45 |
| EPS | N/A | ★ 3.79 |
| Revenue | $392,755,000.00 | ★ $3,736,643,000.00 |
| Revenue This Year | $22.70 | $10.43 |
| Revenue Next Year | $19.14 | $5.46 |
| P/E Ratio | ★ N/A | $22.51 |
| Revenue Growth | N/A | ★ 9.80 |
| 52 Week Low | $41.50 | $56.34 |
| 52 Week High | $59.68 | $106.58 |
| Indicator | SUPN | CMPR |
|---|---|---|
| Relative Strength Index (RSI) | 29.75 | 33.98 |
| Support Level | N/A | $80.73 |
| Resistance Level | $52.33 | $105.61 |
| Average True Range (ATR) | 1.28 | 3.03 |
| MACD | -0.38 | -0.26 |
| Stochastic Oscillator | 2.24 | 4.91 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Cimpress PLC helps millions of businesses build brands, stand out, and grow via customized physical marketing products and branded merchandise. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. It has five segments VistaPrint, PrintBrothers, The Print Group, National Pen, and All Other Businesses. Majority of revenue comes from VistaPrint segment which provides graphic design services, VistaCreate for do-it-yourself (DIY) design, etc. It has presence in North America, Europe, and Other. The company generates majority of revenue is from Europe.